Sabzevari Helen 4
4 · PRECIGEN, INC. · Filed Aug 25, 2023
Insider Transaction Report
Form 4
PRECIGEN, INC.PGEN
Sabzevari Helen
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-08-23+141,587→ 1,636,973 total - Sale
Common Stock
2023-08-25$1.53/sh−76,969$117,763→ 1,560,004 total - Exercise/Conversion
Restricted Stock Units
2023-08-23−141,587→ 0 total→ Common Stock (141,587 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
- [F3]Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023.